# A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Pediatric Atopic Dermatitis

> **NCT02748993** · PHASE1,PHASE2 · COMPLETED · sponsor: **Amorepacific Corporation** · enrollment: 56 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** PAC-14028 Cream 0.1%
- **DRUG:** PAC-14028 Cream 0.3%
- **DRUG:** PAC-14028 Cream 1.0%
- **DRUG:** PAC-14028 Cream Vehicle

## Key facts

- **NCT ID:** NCT02748993
- **Lead sponsor:** Amorepacific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03
- **Primary completion:** 2018-09
- **Final completion:** 2018-10
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2018-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02748993

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02748993, "A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Pediatric Atopic Dermatitis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02748993. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*